Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Bliss GVS Pharma Ltd.
Swot
Bliss GVS Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Bliss GVS Pharma Ltd. has 10 Strengths, 10 Weaknesses, 3 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(10)
Opportunity
(3)
Threats
(0)
Others
(3)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Performer, Under Radar Stocks (DVM)
PEG lower than Industry PEG
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
Top Gainers
Insiders bought stocks
Companies with growing costs YoY for long term projects
Decline in Net Profit (QoQ)
Decline in Quarterly Net Profit (YoY)
Declining Net Cash Flow : Companies not able to generate net cash
Major fall in TTM Net Profit
Weak Momentum: Price below Short, Medium and Long Term Averages
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
Companies with improving valuation scores after share price falls
Promoters increasing shareholding QoQ
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
